CYCC Cyclacel Pharmaceuticals Inc.


34,843 Shares Traded
275,332 Average Volume (last 30 days)

as of February 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:10.23%
If Intiated One Month Ago, Shorts Have Realized a Return of:11.24%
If Initiated Five Days ago, Shorts Have Realized a Return of:1.86%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 4.48%
Short Interest488.04 thousand
Float10.88 million
Short Ratio1.59
Market Cap$18.81 million
Market Maker ActivityDaily Short Volume


Premarket Gainers as of 9:05 am (2/21/2018) (SeekingAlpha)
Cyclacel nabs sapacitabine patent in Europe; shares ahead 6% premarket (SeekingAlpha)
Cyclacel Pharmaceuticals (CYCC) Presents At BIO CEO & Investor Conference - Slideshow (SeekingAlpha)
Cyclacel Pharmaceuticals (CYCC) Presents At Noble Financial Capital Markets 14th Annual Investor Conference - Slideshow (SeekingAlpha)
Key events next week - healthcare (SeekingAlpha)
Cyclacel optimistic with subgroup of patients in failed late-stage study of sapacitabine; investors not on board, shares down 7% (SeekingAlpha)
Premarket Losers as of 9:05 am (SeekingAlpha)
Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q3 2017 Results - Earnings Call Transcript (SeekingAlpha)
Cyclacel Pharmaceuticals reports Q3 results (SeekingAlpha)
Premarket Gainers as of 9:05 am (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 30%

Earnings Stats

PE Ratio -0.63
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $2.41
50 Day Moving Average $1.71
52 Week High $10.9
52 Week Low $1.47

Data provided for free by IEX. Questions? Read the FAQ